172. Hypophosphatasia
32 clinical trials,   18 drugs   (DrugBank: 4 drugs),   3 drug target genes,   6 drug target pathways

Searched query = "Hypophosphatasia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000014816
2014/08/1111/08/2014A Multicenter study of the safety and efficacy of Asfotase Alfa (ALXN1215) (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in patients with hypophosphatasia (HPP) hypophosphatasiaDrug: Asfotase Alfa (ALXN1215)
Dose: 6mg/kg/week (divided 3 times a week)
HPP study groupTranslational Research Informatics CenterComplete: follow-up completeNot applicableNot applicableMale and Female20Not selectedJapan
2NCT02456038
(ClinicalTrials.gov)
August 201426/3/2015Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)A Multicenter Study of the Safety and Efficacy of Asfotase Alfa (ALXN1215) (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Patients With Hypophosphatasia (HPP)HypophosphatasiaDrug: Asfotase Alfa (ALXN1215)Translational Research Informatics Center, Kobe, Hyogo, JapanOsaka University Graduate School of MedicineCompletedN/AN/ABoth13Phase 2Japan